Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredients:||Avibactam sodium 543.5mg equivalent to avibactam 500mg
Ceftazidime pentahydrate 2329.7mg equivalent to ceftazidime 2000mg
|Dosage Form:||Powder for infusion concentrate|
|New Zealand Sponsor:||Pfizer New Zealand Limited|
|Manufacturer:||GlaxoSmithKline Manufacturing SpA, Verona, Italy|
Dated this 19th day of May 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).